Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Invested Capital (2020 - 2023)

Historic Return on Invested Capital for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to 0.13%.

  • ADC Therapeutics' Return on Invested Capital rose 7600.0% to 0.13% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.13%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 0.0% for FY2022, which is N/A changed from last year.
  • ADC Therapeutics' Return on Invested Capital amounted to 0.13% in Q3 2023, which was up 7600.0% from 0.13% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Invested Capital registered a high of 0.0% during Q3 2020, and its lowest value of 2157.54% during Q3 2021.
  • For the 4-year period, ADC Therapeutics' Return on Invested Capital averaged around 361.42%, with its median value being 0.83% (2022).
  • As far as peak fluctuations go, ADC Therapeutics' Return on Invested Capital crashed by -21575400bps in 2021, and later surged by 21566500bps in 2022.
  • Quarter analysis of 4 years shows ADC Therapeutics' Return on Invested Capital stood at 0.0% in 2020, then tumbled by -69999789bps to 1054.42% in 2021, then surged by 100bps to 0.32% in 2022, then surged by 58bps to 0.13% in 2023.
  • Its Return on Invested Capital was 0.13% in Q3 2023, compared to 0.13% in Q2 2023 and 0.36% in Q1 2023.